SLC-0111 enaminone analogs, 3/4-(3-aryl-3-oxopropenyl) aminobenzenesulfonamides, as novel selective subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform IX
Wagdy M. Eldehna(Kafrelsheikh University), Claudiu T. Supuran(University of Florence), Amal Alharbi(King Saud University), Ghada S. Hassan(Mansoura University), Daniela Vullo(University of Florence), Sara T. Al‐Rashood(King Saud University), Hatem A. Abdel‐Aziz(King Saud University), Mahmoud F. Abo-Ashour(Egyptian Russian University), Hazem A. Ghabbour(Mansoura University), Hamad M. Alkahtani(King Saud University), Emanuela Berrino(Link Campus University)
Cited by 66
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5k
Interfering with pH regulation in tumours as a therapeutic strategy
|Nature Reviews Drug Discovery|2011|1.5k
How many carbonic anhydrase inhibition mechanisms exist?
|Journal of Enzyme Inhibition and Medicinal Chemistry|2015|724
Structure-based drug discovery of carbonic anhydrase inhibitors
|Journal of Enzyme Inhibition and Medicinal Chemistry|2012|608